Head and Neck Neuroendocrine Carcinoma — Trials

Head and Neck Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 27
Recruiting: 10
Ph III recruiting: 1
Growth YoY: —
Industry share: 30%
Top sponsor: Eli Lilly and Company
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05675605	A Study of TY-1091 in Patients With Advanced Solid Tumors	unknown	Phase 1 / Phase 2	248	TYK Medicines, IncINDUSTRY	1	Jan 30, 2024	clinicaltrials
NCT05278364	Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor	unknown	Phase 1 / Phase 2	184	Shouyao Holdings (Beijing) Co. LTDOTHER	1	Apr 12, 2023	clinicaltrials